Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Amethyst Exploration, LLC, 50902-50903 [2021-19629]
Download as PDF
<![CDATA[
lotter on DSK11XQN23PROD with NOTICES1
50902
Federal Register / Vol. 86, No. 174 / Monday, September 13, 2021 / Notices
materials were transferred to the
Museum the same year. The human
remains include one fragmentary
skeleton of an adult female, 35–50 years
old; one fragmentary skeleton of an
adult male, 35–50 years old; one
fragmentary skeleton of an adult
probable male, 35–50 years old; one
fragmentary skeleton of an adult of
indeterminate sex, 20–35 years old; two
fragmentary skeletons of adults of
indeterminate sex, each more than 20
years old; one fragmentary skeleton of
an adult of indeterminate sex, 35–50
years old; two fragmentary skeletons of
adults greater of indeterminate sex, each
more than 50 years old; and one
fragmentary set of teeth belonging to an
adult of indeterminate sex and age. No
known individuals were identified.
The 1,103 associated funerary objects
are: Four Avery Engraved type ceramic
bowls, one Avery Engraved type
ceramic bottle, 162 Avery Engraved type
potsherds, two Emory Punctate type
ceramic jars with castellated rims, one
Simms Engraved type ceramic carinated
bowl, 61 Simms Engraved type ceramic
potsherds, six decorated ceramic bowls,
one decorated ceramic jar, one
decorated ceramic bottle, one decorated
ceramic vessel with four applique nodes
with rattles, one decorated ceramic
vessel with four animal effigies on the
rim, four undecorated ceramic bowls,
one undecorated ceramic jar, one
undecorated ceramic red olla vessel,
two ceramic rattle fragments, 390
decorated potsherds, 352 undecorated
potsherds, three ceramic pipe fragments,
31 small corner-notched projectile
points, two Gary type projectile points,
one chipped stone flake, one fragment of
fire cracked rock, one stone celt, four
pigment stones, one unmodified stone,
two copper covered shell earspools, four
faunal bone fragments, 17 shell beads,
one engraved shell gorget, four engraved
shell fragments, 26 shell fragments, four
wood fragments, five charred corn cob
fragments, one seed bead with sediment,
two soil samples with possible textile
matting, one charcoal sample from a
vessel, and one daub fragment.
While the Clement 1 site (34Mc8)
includes both historic and prehistoric
components, all the human remains and
associated funerary objects listed in this
notice belong to the prehistoric
component. Based on an analysis of the
diagnostic cultural materials from the
site (chipped and ground stone,
ceramics, bone tools, and ornaments), as
well as radiocarbon dates obtained from
more recent investigations there, the
prehistoric component of the site dates
to A.D. 1200–1500. Archeological, oral
traditional, and post-contact European
historical information reasonably show
VerDate Sep<11>2014
17:39 Sep 10, 2021
Jkt 253001
that a cultural affiliation exists between
the earlier group connected to the
human remains and associated funerary
objects at the Clement I site and the
present-day Caddo Nation of Oklahoma.
Determinations Made by the Sam Noble
Oklahoma Museum of Natural History
Officials of the Sam Noble Oklahoma
Museum of Natural History have
determined that:
• Pursuant to 25 U.S.C. 3001(9), the
human remains described in this notice
represent the physical remains of 10
individuals of Native American
ancestry.
• Pursuant to 25 U.S.C. 3001(3)(A),
the 1,103 objects described in this
notice are reasonably believed to have
been placed with or near individual
human remains at the time of death or
later as part of the death rite or
ceremony.
• Pursuant to 25 U.S.C. 3001(2), there
is a relationship of shared group
identity that can be reasonably traced
between the Native American human
remains and associated funerary objects
and the Caddo Nation of Oklahoma.
Additional Requestors and Disposition
Lineal descendants or representatives
of any Indian Tribe or Native Hawaiian
organization not identified in this notice
that wish to request transfer of control
of these human remains and associated
funerary objects should submit a written
request with information in support of
the request to Dr. Marc Levine,
Associate Curator of Archaeology, Sam
Noble Oklahoma Museum of Natural
History, University of Oklahoma, 2401
Chautauqua Avenue, Norman, OK
73072–7029, telephone (405) 325–1994,
email mlevine@ou.edu, by October 13,
2021. After that date, if no additional
requestors have come forward, transfer
of control of the human remains and
associated funerary objects to the Caddo
Nation of Oklahoma may proceed.
The Sam Noble Oklahoma Museum of
Natural History is responsible for
notifying the Caddo Nation of Oklahoma
and The Choctaw Nation of Oklahoma
that this notice has been published.
Dated: August 25, 2021.
Melanie O’Brien,
Manager, National NAGPRA Program.
[FR Doc. 2021–19691 Filed 9–10–21; 8:45 am]
BILLING CODE 4312–52–P
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–892]
Bulk Manufacturer of Controlled
Substances Application: Bulk
Manufacturer of Marihuana: Amethyst
Exploration, LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
The Drug Enforcement
Administration (DEA) is providing
notice of an application it has received
from an entity applying to be registered
to manufacture in bulk basic class(es) of
controlled substances listed in schedule
I. DEA intends to evaluate this and other
pending applications according to its
regulations governing the program of
growing marihuana for scientific and
medical research under DEA
registration.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefor, may file written
comments on or objections to the
issuance of the proposed registration on
or before November 12, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW 8701
Morrissette Drive, Springfield, Virginia
22152. To ensure proper handling of
comments, please reference Docket
No—DEA–XXX in all correspondence,
including attachments.
SUPPLEMENTARY INFORMATION: The
Controlled Substances Act (CSA)
prohibits the cultivation and
distribution of marihuana except by
persons who are registered under the
CSA to do so for lawful purposes. In
accordance with the purposes specified
in 21 CFR 1301.33(a), DEA is providing
notice that the entity identified below
has applied for registration as a bulk
manufacturer of schedule I controlled
substances. In response, registered bulk
manufacturers of the affected basic
class(es), and applicants therefor, may
file written comments on or objections
of the requested registration, as
provided in this notice. This notice does
not constitute any evaluation or
determination of the merits of the
application submitted.
The applicant plans to manufacture
bulk active pharmaceutical ingredients
(APIs) for product development and
distribution to DEA registered
researchers. If the application for
registration is granted, the registrant
would not be authorized to conduct
DATES:
E:\FR\FM\13SEN1.SGM
13SEN1
50903
Federal Register / Vol. 86, No. 174 / Monday, September 13, 2021 / Notices
other activity under this registration
aside from those coincident activities
specifically authorized by DEA
regulations. DEA will evaluate the
application for registration as a bulk
manufacturer for compliance with all
applicable laws, treaties, and
regulations and to ensure adequate
safeguards against diversion are in
place.
As this applicant has applied to
become registered as a bulk
manufacturer of marihuana, the
application will be evaluated under the
criteria of 21 U.S.C. 823(a). DEA will
conduct this evaluation in the manner
described in the rule published at 85 FR
82333 on December 18, 2020, and
reflected in DEA regulations at 21 CFR
part 1318.
In accordance with 21 CFR
1301.33(a), DEA is providing notice that
on July 1, 2021, Amethyst Exploration,
LLC., 4210 Jewell Road, Sparta, Georgia
31087, applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substances:
Drug
code
Controlled substance
Marihuana Extract .........
Marihuana ......................
Tetrahydrocannabinols ..
I
7350
7360
7370
Schedule
I
I
I
I
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021–19629 Filed 9–10–21; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–899]
lotter on DSK11XQN23PROD with NOTICES1
I
I
I
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances for
product development and reference
standards. In reference to drug codes
7360 (Marihuana) and 7370
(Tetrahydrocannabinols), the company
plans to isolate these controlled
substances from procured 7350
(Marihuana Extract). In reference to
drug code 7360, no cultivation activities
are authorized for this registration. In
reference to drug code 9333 (Thebaine),
the company plans to manufacture a
Thebaine derivative. No other activities
for these drug codes are authorized for
this registration.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Eli-Elsohly Laboratories has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplementary Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before November 12, 2021. Such
persons may also file a written request
for a hearing on the application on or
before November 12, 2021.
Jkt 253001
7350
7360
7370
1100
1105
9041
9050
9120
9180
9333
Schedule
BILLING CODE P
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
17:39 Sep 10, 2021
Marihuana Extract .........
Marihuana ......................
Tetrahydrocannabinols ..
Amphetamine ................
Methamphetamine .........
Cocaine .........................
Codeine .........................
Dihydrocodeine ..............
Ecgonine ........................
Thebaine ........................
Drug
code
[FR Doc. 2021–19679 Filed 9–10–21; 8:45 am]
AGENCY:
VerDate Sep<11>2014
Controlled substances
Brian S. Bresser,
Acting Assistant Administrator.
Bulk Manufacturer of Controlled
Substances Application: Eli-Elsohly
Laboratories
SUMMARY:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on August 5, 2021, EliElsohly Laboratories, 5 Industrial Park
Drive, Oxford, Mississippi 38655,
applied to be registered as an bulk
manufacturer of the following basic
class(es) of controlled substance(s):
ADDRESSES:
[Docket No. DEA–897]
Importer of Controlled Substances
Application: Aurobindo Pharma USA,
Inc.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before October 13, 2021. Such
persons may also file a written request
for a hearing on the application on or
before October 13, 2021.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on July 20, 2021,
Aurobindo Pharma USA, Inc., 6
Wheeling Road, Dayton, New Jersey
08810–1526, applied to be registered as
an importer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Drug
code
Controlled substance
Remifentanil ...................
I
9739
Brian S. Besser,
Acting Assistant Administrator.
Aurobindo Pharma USA, Inc.
has applied to be registered as an
importer of basic class(es) of controlled
substance(s). Refer to Supplementary
Information listed below for further
drug information.
BILLING CODE P
SUMMARY:
PO 00000
Frm 00033
Fmt 4703
Sfmt 9990
III
The company plans to import
Remifentanil (9739) in bulk form for
research and development. No other
activity for this drug code is authorized
for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Schedule
[FR Doc. 2021–19631 Filed 9–10–21; 8:45 am]
E:\FR\FM\13SEN1.SGM
13SEN1
]]>Agencies
[Federal Register Volume 86, Number 174 (Monday, September 13, 2021)]
[Notices]
[Pages 50902-50903]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-19629]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-892]
Bulk Manufacturer of Controlled Substances Application: Bulk
Manufacturer of Marihuana: Amethyst Exploration, LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: The Drug Enforcement Administration (DEA) is providing notice
of an application it has received from an entity applying to be
registered to manufacture in bulk basic class(es) of controlled
substances listed in schedule I. DEA intends to evaluate this and other
pending applications according to its regulations governing the program
of growing marihuana for scientific and medical research under DEA
registration.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefor, may file written comments on or objections to
the issuance of the proposed registration on or before November 12,
2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW 8701
Morrissette Drive, Springfield, Virginia 22152. To ensure proper
handling of comments, please reference Docket No--DEA-XXX in all
correspondence, including attachments.
SUPPLEMENTARY INFORMATION: The Controlled Substances Act (CSA)
prohibits the cultivation and distribution of marihuana except by
persons who are registered under the CSA to do so for lawful purposes.
In accordance with the purposes specified in 21 CFR 1301.33(a), DEA is
providing notice that the entity identified below has applied for
registration as a bulk manufacturer of schedule I controlled
substances. In response, registered bulk manufacturers of the affected
basic class(es), and applicants therefor, may file written comments on
or objections of the requested registration, as provided in this
notice. This notice does not constitute any evaluation or determination
of the merits of the application submitted.
The applicant plans to manufacture bulk active pharmaceutical
ingredients (APIs) for product development and distribution to DEA
registered researchers. If the application for registration is granted,
the registrant would not be authorized to conduct
[[Page 50903]]
other activity under this registration aside from those coincident
activities specifically authorized by DEA regulations. DEA will
evaluate the application for registration as a bulk manufacturer for
compliance with all applicable laws, treaties, and regulations and to
ensure adequate safeguards against diversion are in place.
As this applicant has applied to become registered as a bulk
manufacturer of marihuana, the application will be evaluated under the
criteria of 21 U.S.C. 823(a). DEA will conduct this evaluation in the
manner described in the rule published at 85 FR 82333 on December 18,
2020, and reflected in DEA regulations at 21 CFR part 1318.
In accordance with 21 CFR 1301.33(a), DEA is providing notice that
on July 1, 2021, Amethyst Exploration, LLC., 4210 Jewell Road, Sparta,
Georgia 31087, applied to be registered as a bulk manufacturer of the
following basic class(es) of controlled substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana Extract...................... 7350 I
Marihuana.............................. 7360 I
Tetrahydrocannabinols.................. 7370 I
------------------------------------------------------------------------
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-19629 Filed 9-10-21; 8:45 am]
BILLING CODE 4410-09-P
